Pathology Unit
Federica Pieri has not added Biography.
If you are Federica Pieri and would like to personalize this page please email our Author Liaison for assistance.
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.
OncoTargets and therapy , 2014 | Pubmed ID: 25364262
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report.
BMC cancer Dec, 2015 | Pubmed ID: 26695071
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.
International journal of molecular sciences Aug, 2016 | Pubmed ID: 27556456
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas.
OncoTargets and therapy , 2016 | Pubmed ID: 27785071
Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.
Biology open Feb, 2017 | Pubmed ID: 27895047
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.
Molecules (Basel, Switzerland) Dec, 2016 | Pubmed ID: 27918490
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of (18)FDG-PET/CT.
Clinical lung cancer Jul, 2017 | Pubmed ID: 27956089
Management and potentialities of primary cancer cultures in preclinical and translational studies.
Journal of translational medicine Nov, 2017 | Pubmed ID: 29116016
Primary leiomyosarcoma of the bone: a case report and a review of the literature.
Medicine Nov, 2017 | Pubmed ID: 29137065
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
International journal of molecular sciences Dec, 2017 | Pubmed ID: 29292724
Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
Therapeutic advances in medical oncology Dec, 2017 | Pubmed ID: 29449896
Copyright © 2024 MyJoVE Corporation. 판권 소유